{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:02:19Z","timestamp":1790906539528,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T00:00:00Z","timestamp":1158710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2007,1,19]]},"DOI":"10.1007\/s11060-006-9227-9","type":"journal-article","created":{"date-parts":[[2006,10,9]],"date-time":"2006-10-09T04:13:48Z","timestamp":1160367228000},"page":"241-248","source":"Crossref","is-referenced-by-count":40,"title":["PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium"],"prefix":"10.1007","volume":"81","author":[{"given":"Robert M.","family":"Beaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Mei","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Riggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,20]]},"reference":[{"key":"9227_CR1","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1158\/0008-5472.CAN-04-1337","volume":"64","author":"H Ohgaki","year":"2004","unstructured":"Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892\u20136899","journal-title":"Cancer Res"},{"key":"9227_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol (Berl) 109:93\u2013108","journal-title":"Acta Neuropathol (Berl)"},{"key":"9227_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1998.88.1.0001","volume":"88","author":"FG Davis","year":"1998","unstructured":"Davis FG, Freels S, Grutsch J, Barlas S, Brem S (1998) Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (seer) data, 1973\u20131991. J Neurosurg 88:1\u201310","journal-title":"J Neurosurg"},{"key":"9227_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/neuonc\/1.1.44","volume":"1","author":"P Kleihues","year":"1999","unstructured":"Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1:44\u201351","journal-title":"Neuro-oncol"},{"key":"9227_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/neuonc\/2.3.164","volume":"2","author":"RN Wiltshire","year":"2000","unstructured":"Wiltshire RN, Rasheed BK, Friedman HS, Friedman AH, Bigner SH (2000) Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neuro-oncol 2:164\u2013173","journal-title":"Neuro-oncol"},{"key":"9227_CR6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/jnci\/93.17.1337","volume":"93","author":"A Lal","year":"2001","unstructured":"Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:1337\u20131343","journal-title":"J Natl Cancer Inst"},{"key":"9227_CR7","first-page":"6885","volume":"61","author":"DS Rickman","year":"2001","unstructured":"Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, Taylor J, Hanash SM (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61:6885\u20136891","journal-title":"Cancer Res"},{"key":"9227_CR8","first-page":"3335","volume":"62","author":"A Lal","year":"2002","unstructured":"Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH, Riggins GJ (2002) Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res 62:3335\u20133339","journal-title":"Cancer Res"},{"key":"9227_CR9","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/sj.onc.1206344","volume":"22","author":"PS Mischel","year":"2003","unstructured":"Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22:2361\u20132373","journal-title":"Oncogene"},{"key":"9227_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2407-4-39","volume":"4","author":"K Boon","year":"2004","unstructured":"Boon K, Edwards JB, Eberhart CG, Riggins GJ (2004) Identification of astrocytoma associated genes including cell surface markers. BMC Cancer 4:39","journal-title":"BMC Cancer"},{"key":"9227_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1593\/neo.04535","volume":"7","author":"DB Hoelzinger","year":"2005","unstructured":"Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7\u201316","journal-title":"Neoplasia"},{"key":"9227_CR12","unstructured":"Giese A, Loo MA, Rief MD, Tran N, Berens ME (1995) Substrates for astrocytoma invasion. Neurosurgery 37:294\u2013301; discussion 301\u2013292"},{"key":"9227_CR13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00005072-199910000-00001","volume":"58","author":"CL Gladson","year":"1999","unstructured":"Gladson CL (1999) The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58:1029\u20131040","journal-title":"J Neuropathol Exp Neurol"},{"key":"9227_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/glia.1124","volume":"36","author":"N Belot","year":"2001","unstructured":"Belot N, Rorive S, Doyen I, Lefranc F, Bruyneel E, Dedecker R, Micik S, Brotchi J, Decaestecker C, Salmon I, Kiss R, Camby I (2001) Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 36:375\u2013390","journal-title":"Glia"},{"key":"9227_CR15","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.2741\/897","volume":"8","author":"RD Rao","year":"2003","unstructured":"Rao RD, Uhm JH, Krishnan S, James CD (2003) Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies. Front Biosci 8:e270\u2013e280","journal-title":"Front Biosci"},{"key":"9227_CR16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.biocel.2004.01.013","volume":"36","author":"AC Bellail","year":"2004","unstructured":"Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046\u20131069","journal-title":"Int J Biochem Cell Biol"},{"key":"9227_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc1121","volume":"3","author":"JS Rao","year":"2003","unstructured":"Rao JS (2003) Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3:489\u2013501","journal-title":"Nat Rev Cancer"},{"key":"9227_CR18","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1200\/JCO.2005.03.089","volume":"23","author":"F Lefranc","year":"2005","unstructured":"Lefranc F, Brotchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411\u20132422","journal-title":"J Clin Oncol"},{"key":"9227_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00130404-200305000-00008","volume":"9","author":"O Bogler","year":"2003","unstructured":"Bogler O, Mikkelsen T (2003)Angiogenesis in glioma: Molecular mechanisms and roadblocks to translation. Cancer J 9:205\u2013213","journal-title":"Cancer J"},{"key":"9227_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-004-2752-5","volume":"70","author":"B Kaur","year":"2004","unstructured":"Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG (2004) Genetic and hypoxic regulation of angiogenesis in gliomas. J. Neurooncol 70:229\u2013243","journal-title":"J. Neurooncol"},{"key":"9227_CR21","doi-asserted-by":"crossref","unstructured":"Kargiotis O, Rao JS, Kyritsis AP (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol","DOI":"10.1007\/s11060-005-9097-6"},{"key":"9227_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresrev.2004.03.001","volume":"45","author":"M Jansen","year":"2004","unstructured":"Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ (2004) Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev 45:143\u2013163","journal-title":"Brain Res Brain Res Rev"},{"key":"9227_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jcb.20475","volume":"96","author":"O Bogler","year":"2005","unstructured":"Bogler O, Mikkelsen T (2005) Angiogenesis and apoptosis in glioma: Two arenas for promising new therapies. J Cell Biochem 96:16\u201324","journal-title":"J Cell Biochem"},{"key":"9227_CR24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"B St Croix","year":"2000","unstructured":"St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 289:1197\u20131202","journal-title":"Science"},{"key":"9227_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)63324-X","volume":"165","author":"BP SL Madden","year":"2004","unstructured":"SL, Madden BP, Cook M, Nacht WD, Weber MR, Callahan Y, Jiang MR, Dufault X, Zhang W, Zhang J, Walter-Yohrling C, Rouleau VR, Akmaev CJ, Wang X, Cao TB, St Martin BL, Roberts BA, Teicher KW, Klinger RV, Stan B, Lucey EB, Carson-Walter J, Laterra KA, Walter (2004) Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 165:601\u2013608","journal-title":"Am J Pathol"},{"key":"9227_CR26","first-page":"463","volume":"222","author":"K Boon","year":"2003","unstructured":"Boon K, Riggins GJ (2003) Sage as a strategy to isolate cancer-related genes. Methods Mol Biol 222:463\u2013479","journal-title":"Methods Mol Biol"},{"key":"9227_CR27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nsb0901-784","volume":"8","author":"KS Wendt","year":"2001","unstructured":"Wendt KS, Vodermaier HC, Jacob U, Gieffers C, Gmachl M, Peters JM, Huber R, Sondermann P (2001) Crystal structure of the apc10\/doc1 subunit of the human anaphase-promoting complex. Nat Struct Biol 8:784\u2013788","journal-title":"Nat Struct Biol"},{"key":"9227_CR28","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1074\/jbc.274.20.14500","volume":"274","author":"R Grossberger","year":"1999","unstructured":"Grossberger R, Gieffers C, Zachariae W, Podtelejnikov AV, Schleiffer A, Nasmyth K, Mann M, Peters JM (1999) Characterization of the doc1\/apc10 subunit of the yeast and the human anaphase-promoting complex. J Biol Chem 274:14500\u201314507","journal-title":"J Biol Chem"},{"key":"9227_CR29","first-page":"6649","volume":"61","author":"EB Carson-Walter","year":"2001","unstructured":"Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B (2001) Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61:6649\u20136655","journal-title":"Cancer Res"},{"key":"9227_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.molbrainres.2005.02.010","volume":"136","author":"HK Lee","year":"2005","unstructured":"Lee HK, Bae HR, Park HK, Seo IA, Lee EY, Suh DJ (2005) Park HT Cloning, characterization and neuronal expression profiles of tumor endothelial marker 7 in the rat brain. Brain Res. Mol Brain Res 136:189\u2013198","journal-title":"Mol Brain Res"},{"key":"9227_CR31","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1158\/0008-5472.CAN-04-2716","volume":"64","author":"A Nanda","year":"2004","unstructured":"Nanda A, Buckhaults P, Seaman S, Agrawal N, Boutin P, Shankara S, Nacht M, Teicher B, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B (2004) Identification of a binding partner for the endothelial cell surface proteins tem7 and tem7r. Cancer Res 64:8507\u20138511","journal-title":"Cancer Res"},{"key":"9227_CR32","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.febslet.2006.03.033","volume":"580","author":"HK Lee","year":"2006","unstructured":"Lee HK, Seo IA, Park HK, Park HT (2006) Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo. FEBS Lett 580:2253\u20132257","journal-title":"FEBS Lett"},{"key":"9227_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.mvr.2005.08.004","volume":"70","author":"XQ Wang","year":"2005","unstructured":"Wang XQ, Sheibani N, Watson JC (2005) Modulation of tumor endothelial cell marker 7 expression during endothelial cell capillary morphogenesis. Microvasc Res 70:189\u2013197","journal-title":"Microvasc Res"},{"key":"9227_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1681\/ASN.V133621","volume":"13","author":"D Zehnder","year":"2002","unstructured":"Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM, Hewison M (2002) Synthesis of 1,25\u2013dihydroxyvitamin d (3) by human endothelial cells is regulated by inflammatory cytokines: A novel autocrine determinant of vascular cell adhesion. J.Am Soc Nephrol 13:621\u2013629","journal-title":"J.Am Soc Nephrol"},{"key":"9227_CR35","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/1078-0432.CCR-04-1968","volume":"11","author":"B Diesel","year":"2005","unstructured":"Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, Reichrath J, Fischer U, Meese E (2005) Vitamin d (3) metabolism in human glioblastoma multiforme: Functionality of cyp27b1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res 11:5370\u20135380","journal-title":"Clin Cancer Res"},{"key":"9227_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/erc.1.00920","volume":"12","author":"PP Dwivedi","year":"2005","unstructured":"Dwivedi PP, Anderson PH, Omdahl JL, Grimes HL, Morris HA, May BK (2005) Identification of growth factor independent-1 (gfi1) as a repressor of 25\u2013hydroxyvitamin d 1-alpha hydroxylase (cyp27b1) gene expression in human prostate cancer cells. Endocr Relat Cancer 12:351\u2013365","journal-title":"Endocr Relat Cancer"},{"key":"9227_CR37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JCO.2004.08.110","volume":"22","author":"JN Rich","year":"2004","unstructured":"Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon RE, Kao JC, Stenzel TT, Ahmed Rasheed BK, Tourt-Uhlig SE, Herndon JE 2nd, Vredenburgh JJ, Sampson JH, Friedman AH, Bigner DD, Friedman HS (2004) Phase ii trial of gefitinib in recurrent glioblastoma. J Clin Oncol 22:133\u2013142","journal-title":"J Clin Oncol"},{"key":"9227_CR38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jnci\/dji161","volume":"97","author":"DA Haas-Kogan","year":"2005","unstructured":"Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D (2005) Epidermal growth factor receptor, protein kinase b\/akt, and glioma response to erlotinib. J Natl Cancer Inst 97:880\u2013887","journal-title":"J Natl Cancer Inst"},{"key":"9227_CR39","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa051918","volume":"353","author":"IK Mellinghoff","year":"2005","unstructured":"Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS (2005) Molecular determinants of the response of glioblastomas to egfr kinase inhibitors. N Engl J Med 353:2012\u20132024","journal-title":"N Engl J Med"},{"key":"9227_CR40","first-page":"2554","volume":"62","author":"A Hirata","year":"2002","unstructured":"Hirata A, Ogawa S, Kometani T, Kuwano T, Naito S, Kuwano M, Ono M (2002) Zd1839 (iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 62:2554\u20132560","journal-title":"Cancer Res"},{"key":"9227_CR41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1349-7006.2004.tb02496.x","volume":"95","author":"A Hirata","year":"2004","unstructured":"Hirata A, Uehara H, Izumi K, Naito S, Kuwano M, Ono M (2004) Direct inhibition of egf receptor activation in vascular endothelial cells by gefitinib (\u2018iressa\u2019, zd1839). Cancer Sci 95:614\u2013618","journal-title":"Cancer Sci"},{"key":"9227_CR42","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1158\/1535-7163.MCT-05-0108","volume":"4","author":"A Bozec","year":"2005","unstructured":"Bozec A, Formento P, Ciccolini J, Fanciullino R, Padovani L, Murraciole X, Fischel JL, Milano G (2005) Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation. Mol Cancer Ther 4:1962\u20131971","journal-title":"Mol Cancer Ther"},{"key":"9227_CR43","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1158\/1078-0432.CCR-05-0816","volume":"11","author":"K Yoshiura","year":"2005","unstructured":"Yoshiura K, Nakaoka T, Nishishita T, Sato K, Yamamoto A, Shimada S, Saida T, Kawakami Y, Takahashi TA, Fukuda H, Imajoh-Ohmi S, Oyaizu N, Yamashita N (2005) Carbonic anhydrase ii is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 11:8201\u20138207","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-006-9227-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9227-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T23:43:09Z","timestamp":1627861389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-006-9227-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,20]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1,19]]}},"alternative-id":["9227"],"URL":"https:\/\/doi.org\/10.1007\/s11060-006-9227-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,20]]}}}